Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model (Q33704554)

28 July 2017

title

Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model (English)

1 reference

28 July 2017

7

Håkan Arheden

1 reference

28 July 2017

4

Matthias Götberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

21 July 2024

6

Mikael Kanski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

21 July 2024

author name string

Jesper van der Pals

1

1 reference

28 July 2017

Sasha Koul

2

1 reference

28 July 2017

Patrik Andersson

3

1 reference

28 July 2017

Bengt Larsson

9

1 reference

28 July 2017

David Erlinge

10

1 reference

28 July 2017

Joey F. A. Ubachs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

21 July 2024

Göran K. Olivecrona

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

21 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20875134

21 July 2024

publication date

27 September 2010

1 reference

full work available at URL

28 July 2017

https://bmccardiovascdisord.biomedcentral.com/counter/pdf/10.1186/1471-2261-10-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

http://www.biomedcentral.com/1471-2261/10/45/abstract

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

http://www.biomedcentral.com/content/pdf/1471-2261-10-45.pdf

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20875134/?tool=EBI

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

http://www.biomedcentral.com/1471-2261/10/45

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20875134/pdf/?tool=EBI

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

https://europepmc.org/articles/PMC2955599

21 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

https://europepmc.org/articles/PMC2955599?pdf=render

21 July 2024

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20875134

http://link.springer.com/content/pdf/10.1186/1471-2261-10-45.pdf

21 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

http://link.springer.com/article/10.1186/1471-2261-10-45/fulltext.html

21 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

http://link.springer.com/content/pdf/10.1186/1471-2261-10-45

21 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

https://link.springer.com/content/pdf/10.1186/1471-2261-10-45.pdf

21 July 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

BMC Cardiovascular Disorders

21 July 2024

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

45

1 reference

Microvascular obstruction: underlying pathophysiology and clinical diagnosis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Design and validation of Segment--freely available software for cardiovascular image analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Epicardial temperature is a major predictor of myocardial infarct size in dogs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Does reperfusion injury exist in humans?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Complement localization and mediation of ischemic injury in baboon myocardium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Effects of complement activation in the isolated heart. Role of the terminal complement components

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Reperfusion induced injury: manifestations, mechanisms, and clinical relevance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus--an anti-inflammatory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955599

Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-10-45

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

21 January 2018

1 reference

12 December 2020

C5aR-mediated myocardial ischemia/reperfusion injury

1 reference

12 December 2020

Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction

1 reference

12 December 2020

Apoptosis in human acute myocardial infarction

1 reference

12 December 2020

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury

1 reference

12 December 2020

Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo

1 reference

12 December 2020

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

1 reference

12 December 2020

Lethal Myocardial Reperfusion Injury: Does it Exist, Should We Treat It?

1 reference

12 December 2020

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

12 December 2020

Federation Proceedings

19

46

2407

R Engler

1987

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

American Journal of Physiology

21 July 2024

36

268

H448

EA Amsterdam

1995

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

Pexelizumab and the APEX AMI trial

21 July 2024

42

1 reference

https://api.crossref.org/works/10.1186/1471-2261-10-45

21 July 2024

Identifiers

1 reference

Dimensions Publication ID

28 July 2017

1038367004

0 references

Fatcat ID

release_ivrjodalyjcnvk7fluoml6timq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ivrjodalyjcnvk7fluoml6timq

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2955599

1 reference

28 July 2017

1 reference